TIAA CREF Investment Management’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $4.74M | Sell |
496,753
-41,118
| -8% | -$392K | ﹤0.01% | 1484 |
|
|
2018
Q4 | $6.18M | Sell |
537,871
-19,955
| -4% | -$229K | ﹤0.01% | 1242 |
|
|
2018
Q3 | $9.46M | Buy |
557,826
+45,520
| +9% | +$772K | 0.01% | 1134 |
|
|
2018
Q2 | $7.28M | Sell |
512,306
-72,232
| -12% | -$1.03M | ﹤0.01% | 1347 |
|
|
2018
Q1 | $11.1M | Sell |
584,538
-298,844
| -34% | -$5.68M | 0.01% | 1054 |
|
|
2017
Q4 | $14.5M | Buy |
883,382
+164,900
| +23% | +$2.7M | 0.01% | 930 |
|
|
2017
Q3 | $10.8M | Buy |
718,482
+511,919
| +248% | +$7.68M | 0.01% | 1106 |
|
|
2017
Q2 | $1.82M | Sell |
206,563
-73,549
| -26% | -$647K | ﹤0.01% | 2233 |
|
|
2017
Q1 | $1.46M | Sell |
280,112
-7,429
| -3% | -$38.6K | ﹤0.01% | 2320 |
|
|
2016
Q4 | $877K | Sell |
287,541
-11,780
| -4% | -$35.9K | ﹤0.01% | 2614 |
|
|
2016
Q3 | $1.39K | Sell |
299,321
-17,530
| -6% | -$81 | ﹤0.01% | 2365 |
|
|
2016
Q2 | $1.84M | Buy |
316,851
+5,304
| +2% | +$30.7K | ﹤0.01% | 2172 |
|
|
2016
Q1 | $1.89M | Sell |
311,547
-7,844
| -2% | -$47.5K | ﹤0.01% | 2108 |
|
|
2015
Q4 | $2.92M | Hold |
319,391
| – | – | ﹤0.01% | 1923 |
|
|
2015
Q3 | $1.8M | Sell |
319,391
-15,005
| -4% | -$84.6K | ﹤0.01% | 2209 |
|
|
2015
Q2 | $3.71M | Sell |
334,396
-30,672
| -8% | -$340K | ﹤0.01% | 1900 |
|
|
2015
Q1 | $5.72M | Buy |
365,068
+1,574
| +0.4% | +$24.7K | ﹤0.01% | 1540 |
|
|
2014
Q4 | $5.53M | Sell |
363,494
-15,094
| -4% | -$230K | ﹤0.01% | 1564 |
|
|
2014
Q3 | $4.08M | Sell |
378,588
-4,736
| -1% | -$51.1K | ﹤0.01% | 1758 |
|
|
2014
Q2 | $5.85M | Buy |
383,324
+26,300
| +7% | +$402K | ﹤0.01% | 1562 |
|
|
2014
Q1 | $6.46M | Buy |
357,024
+32,492
| +10% | +$587K | ﹤0.01% | 1429 |
|
|
2013
Q4 | $4.51M | Buy |
324,532
+18,480
| +6% | +$257K | ﹤0.01% | 1706 |
|
|
2013
Q3 | $3.21M | Sell |
306,052
-7,503
| -2% | -$78.6K | ﹤0.01% | 1911 |
|
|
2013
Q2 | $2.45M | Buy |
+313,555
| New | +$2.45M | ﹤0.01% | 2037 |
|